4-咔唑-9-基丁酸 | 90053-09-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4-咔唑-9-基丁酸
• 英文名称: 4-(9H-carbazol-9-yl)butanoic acid
• 英文别名: 4-(9H-9-carbazolyl)butanoic acid；4-(carbazol-9-yl)-butyric acid；4-carbazol-9-yl-butyric acid；4-Carbazol-9-yl-buttersaeure；Carbazole butanoic acid；4-carbazol-9-ylbutanoic acid
• CAS: 90053-09-1
• 化学式: C₁₆H₁₅NO₂
• mdl: MFCD09803917
• 分子量: 253.301
• InChiKey: HQAKVYGASUTQHH-UHFFFAOYSA-N

物化性质

• 熔点：
  151 °C
• 沸点：
  424.9±37.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.187
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6,7-二甲氧基-1,2,3,4-四氢异喹啉 、 4-咔唑-9-基丁酸 以 四氢呋喃 为溶剂， 反应 2.0h， 生成
  参考文献：
  名称：

  Potential applications for sigma receptor ligands in cancer diagnosis and therapy

  摘要：

  Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenous ligands may include the hallucinogen N,N-dimethyltryptamine (DMT) and sphingolipid-derived amines which interact with sigma-1 receptors, besides steroid hormones (e.g., progesterone) which bind to both sigma receptor sub-populations. The sigma-1 receptor is a ligand-regulated molecular chaperone with various ion channels and G-protein-coupled membrane receptors as clients. The sigma-2 receptor was identified as the progesterone receptor membrane component 1 (PGRMC1). Although sigma receptors are over-expressed in tumors and up-regulated in rapidly dividing normal tissue, their ligands induce significant cell death only in tumor tissue. Sigma ligands may therefore be used to selectively eradicate tumors. Multiple mechanisms appear to underlie cell killing after administration of sigma ligands, and the signaling pathways are dependent both on the type of ligand and the type of tumor cell. Recent evidence suggests that the sigma-2 receptor is a potential tumor and serum biomarker for humaniung cancer and an important target for inhibiting tumor invasion and cancer progression. Current radiochemical efforts are focused on the development of subtype-selective radioligands for positron emission tomography (PET) imaging. Right now, the mostpromising tracers are [F-18]fluspidine and [F-18]FTC-146 for sigma-1 receptors and [C-11]RHM-1 and [F-18]ISO-1 for the sigma-2 subtype. Nanoparticles coupled to sigma ligands have shown considerable potential for targeted delivery of antitumor drugs in animal models of cancer, but clinical studies exploring this strategy in cancer patients have not yet been reported. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers. (C) 2014 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.bbamem.2014.08.022
• 作为产物：
  描述：

  Methyl 4-carbazol-9-ylbutanoate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 6.0h， 以100%的产率得到4-咔唑-9-基丁酸
  参考文献：
  名称：

  摘要：

  The synthesis of 13 discotic mesogens is described in which the well-known hexakis( pentyloxy) triphenylene liquid crystalline material has been chemically modified to incorporate one, two, three and six carbazole moieties. These modifications have been achieved by the alkylation or esterification of mono-, di-, tri- and hexa-hydroxytriphenylene derivatives with alkyl bromides and carboxylic acids incorporating the carbazole moiety. The pure compounds are not liquid crystalline in nature but when doped with TNF, hexagonal columnar mesophases are induced, as shown by DSC, OPM and X-ray diffraction. These mesophases exist below room temperature. The mesophase clearing temperatures are dependent on several factors including the chain length separating the carbazole moiety from the triphenylene core, and the nature of the ether or ester linkage, and the degree of TNF doping. The data suggest that the most stable mesophases (highest clearing temperatures) are formed when a 2 : 1 complex is formed between the carbazole derivatives and the TNF, respectively. The correlation length obtained from X-ray diffraction reveals that the columnar order for one of the ether derivatives decreases, whereas the correlation length increases for one of the ester derivatives. This result suggests that the TNF is not only partaking in pi-pi noncovalent bonding interactions, but also in polar interactions with the C=O bond. Such mesogenic carbazole derivatives may have advantageous photorefractive properties over the amorphous polymeric materials.

  DOI：

  10.1039/b103052n

文献信息

• Towards hybrid carbazole/pyrrole-based carboxylated monomers: chemical synthesis, characterisation and electro-oxidation properties
  作者：Jean-Paul Lellouche、Zvika Pomerantz、Subrata Ghosh

  DOI：10.1016/j.tetlet.2011.10.047

  日期：2011.12

  Six novel hybrid carbazole (Cbz)–pyrrole (Pyr)-based carboxylated monomers were synthesised and unambiguously characterised using common spectroscopic tools. Clauson-Kaas, amide coupling, LAH (lithium aluminium hydride)-mediated reduction, esterification and debenzylation reactions were used as key chemical reactions towards their multi-step synthesis. The electro-oxidation features of all these six

  合成了六种新颖的杂咔唑（Cbz）-吡咯（Pyr）基羧化单体，并使用常用的光谱学工具对其进行了明确表征。Clauson-Kaas，酰胺偶联，LAH（氢化铝锂）介导的还原，酯化和脱苄基反应被用作实现多步合成的关键化学反应。所有这六个杂种的电氧化特征研究了Cbz / Pyr单体对相应的聚COOH导电涂层的电沉积。非常有趣的是，由于这种可电氧化的单体同时包含两种类型的可氧化杂环，即Pyr和Cbz物种，因此发现这些杂化Cbz / Pyr单体的成功电聚合反应高度依赖于相应单体中Cbz与Pyr单元的相对数量。实际上，仅对于特征为Cbz / Pyr单元比大于或等于1的杂化单体，才观察到将相应的导电聚合物薄膜成功电沉积到工作的Pt电极上。通过适当的化学设计和单体多步合成，系统地调节单体中存在的可氧化Cbz和Pyr单元的数量，已验证了该结果。在这种情况下，循环伏安图分析很容易就证实了电沉积的唯一性。在进行polyCbz
• New propylamine oligopyrrole carboxamides linked to a heterocyclic or anthraquinone system: synthesis, DNA binding, topoisomerase I inhibition and cytotoxicity
  作者：Christian Hotzel、Annalisa Marotto、Ulf Pindur

  DOI：10.1016/s0223-5234(02)01441-1

  日期：2003.2

  studies on combilexines, compounds consisting of a DNA intercalator linked to a minor groove ligand, new results are presented. The synthesis of a series of new propylamine oligopyrrole carboxamides closely related to netropsin and distamycin A, linked to a heterocyclic or anthraquinone system is reported. The cytotoxic activity in vitro, the DNA binding characteristics and the inhibition of the topoisomerase

  继续我们对梳状毒素的研究，该化合物由与小沟配体连接的DNA嵌入剂组成，并提供了新的结果。报道了一系列与netropsin和distamycin A密切相关的，与杂环或蒽醌系统连接的新丙胺低聚吡咯羧酰胺的合成。研究了化合物的体外细胞毒活性，DNA结合特性和对拓扑异构酶I的抑制作用，以解释这些新的潜在组合物的生物学作用机理。一些合成的化合物显示出对人肿瘤细胞系的细胞毒活性，以及​​DNA结合和拓扑异构酶I抑制特性。
• Advanced drug development and manufacturing
  申请人：Los Alamos National Security, LLC

  公开号：EP2511844A2

  公开（公告）日：2012-10-17

  There is described an apparatus for measuring protein characteristics comprising an X-ray fluorescence (XRF) spectrometer comprising a source of polychromatic X-rays, an X-ray detector, a protein, a molecule that has been exposed to and at least weakly binds to the protein, a plurality of X-ray fluorescence signal data obtained by irradiating chemical elements in the protein and molecule with the polychromatic X-rays and a security system for maintaining records for the data from the plurality of X-ray fluorescence signal measurements. There is also described an x-ray microscope for measuring a sample.

  描述了一种测量蛋白质特性的仪器，该仪器包括一个 X 射线荧光 (XRF) 光谱仪，其中包括一个多色 X 射线源、一个 X 射线探测器、一个蛋白质、一个已暴露于该蛋白质并至少与该蛋白质弱结合的分子、通过用多色 X 射线照射蛋白质和分子中的化学元素而获得的多个 X 射线荧光信号数据，以及一个用于维护多个 X 射线荧光信号测量数据记录的安全系统。此外，还介绍了一种用于测量样品的 X 射线显微镜。
• FABP4 as a therapeutic target in skin diseases
  申请人：TICURE LTD.

  公开号：US11229624B2

  公开（公告）日：2022-01-25

  Provided are methods of regulating proliferation and/or differentiation of keratinocytes and immune cells, more specifically to methods of treating pathologies characterized by hyperproliferative keratinocytes or inflammatory skin diseases by administration of FABP4-inhibitor.

  本发明提供了调节角质细胞和免疫细胞增殖和/或分化的方法，更具体地说，提供了通过服用 FABP4 抑制剂治疗以角质细胞过度增殖或炎症性皮肤病为特征的病症的方法。
• From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: Small structural changes address the mechanism of interaction at the efflux pump
  作者：Carmen Abate、Maria Laura Pati、Marialessandra Contino、Nicola Antonio Colabufo、Roberto Perrone、Mauro Niso、Francesco Berardi

  DOI：10.1016/j.ejmech.2014.10.082

  日期：2015.1

  Generations of modulators of the efflux pump P-glycoprotein (P-gp) have been produced as tools to counteract the Multidrug Resistance (MDR) phenomenon in tumor therapy, but clinical trials were not successful so far. With the aim of contributing to the development of novel P-gp modulators, we started from recently studied high-affinity sigma-2 (sigma(2)) receptor ligands that showed also potent interaction with P-gp. For sigma(2) receptors high-affinity binding, a basic N-atom is a strict requirement. Therefore, we reduced the basic character of the N-atom present in these ligands, and we obtained potent P-gp modulators with poor or null sigma(2) receptor affinity. We also evaluated whether modulation of P-gp by these novel compounds involved consumption of ATP (as P-gp substrates do), as a source of energy to support the efflux. Surprisingly, even small structural changes resulted in opposite behavior, with amide 13 depleting ATP, in contrast to its isomer 18. Two compounds, 15 and 25, emerged for their potent activity at P-gp, and deserve further investigations as tools for P-gp modulation. (C) 2014 Elsevier Masson SAS. All rights reserved.